Article
Identification of a synonymous polymorphism within the cytochrome P4502C9 gene that interferes with identification of the CYP2C9*2 allele.
Therapeutic drug monitoring - 1 Oct 2007
Womack Edward P, Reynolds Kristen K, Valdes Roland, Linder Mark W
Abstract excerpt
Cytochrome P450 2C9 (CYP4502C9) genotyping is useful in dosage adjustments for several critical drug therapies, including warfarin. Potential interference compromising these genotyping results could lead to inappropriate dose adjustments that may result in adverse drug reactions. During routine clinical CYP4502C9 genotyping using multiplex allele-specific primer extension, an ambiguous result was obtained for...
Topics
- Aryl Hydrocarbon Hydroxylases
- Cytochrome P-450 CYP2C9
- DNA
- DNA Primers
- Gene Frequency
- Genotype
- Humans
- Polymerase Chain Reaction
- Polymorphism, Single Nucleotide
